← Leaderboards
Arturo Casadevall
Johns Hopkins University
$47,974,076
Attributed
$49,598,340
Total exposure
16
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$59,820,199 · 18
By mechanism
R01$32,531,712 · 7
U19$8,008,502 · 3
T32$7,263,906 · 2
U54$4,442,873 · 2
R37$3,917,600 · 1
U01$3,244,413 · 1
Top collaborators
- Joshua D Nosanchuk3 shared
- Ruth E. Stark3 shared
- David S Perlin1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Cynthia Melinda Boyd$13,738,237
- Joshua D Nosanchuk$4,457,092
- Brian Wilson Weir$124,356
- Ruth E. Stark$6,150,743
- Susanna M Thon$1,151,443
Others in their field
Top investigators on “Cryptococcus Neoformans”
- Joseph Heitman · Duke University$33,924,189
- Hiten D Madhani · University Of California, San Francisco$24,815,163
- Maurizio Del Poeta · Northport Va Medical Center$22,300,489
- Tamara L Doering · Washington University$20,134,929
- Stuart M Levitz · Duke University$16,533,146
- Jennifer K. Lodge · Duke University$14,144,715
Research focus
Cryptococcus NeoformansProgramsFungusAntibodiesMolecularStructurePathogenImmunityInfectionPolysaccharidesFundingCellsBaseAntigensVirulenceMediatingAffectProteinsAcquired Immunodeficiency SyndromeVaccinesPathogenesisPhagocytosisMonoclonal AntibodiesIn Vitro
Grant awards (123)
Accelerator for the rapid development of countermeasures targeting drug resistant fungal pathogens$6,977,446
U19 · FY2025 · AI · contact PI
The biology of Cryptococcus neoformans melanization$785,315
R01 · FY2025 · AI · contact PI
Monoclonal Antibody Therapeutics for Candida auris$748,593
U19 · FY2025 · AI · contact PI
Exploiting antibody catalysis for treating Cryptococcosis$725,763
R01 · FY2025 · AI · contact PI
The Molecular and Cellular Basis of Infectious Diseases (MCBID) Program$462,229
T32 · FY2025 · AI · contact PI
Administrative Core$282,463
U19 · FY2025 · AI · contact PI
The biology of Cryptococcus neoformans melanization$809,603
R01 · FY2024 · AI · contact PI
Exploiting antibody catalysis for treating Cryptococcosis$725,763
R01 · FY2024 · AI · contact PI
Conjugate vaccines for prevention and treatment of cryptococcosis$692,433
R01 · FY2024 · AI · contact PI
The Molecular and Cellular Basis of Infectious Diseases (MCBID) Program$609,749
T32 · FY2024 · AI · contact PI
The biology of Cryptococcus neoformans melanization$841,478
R01 · FY2023 · AI · contact PI
Exploiting antibody catalysis for treating Cryptococcosis$755,763
R01 · FY2023 · AI · contact PI
Conjugate vaccines for prevention and treatment of cryptococcosis$692,433
R01 · FY2023 · AI · contact PI
The Molecular and Cellular Basis of Infectious Diseases (MCBID) Program$603,740
T32 · FY2023 · AI · contact PI
Synergy of Host Defense Mechanisms in the Lung$409,375
R01 · FY2023 · HL · contact PI
Exploiting antibody catalysis for treating Cryptococcosis$757,763
R01 · FY2022 · AI · contact PI
Conjugate vaccines for prevention and treatment of cryptococcosis$692,433
R01 · FY2022 · AI · contact PI
The Molecular and Cellular Basis of Infectious Diseases (MCBID) Program$564,671
T32 · FY2022 · AI · contact PI
Synergy of Host Defense Mechanisms in the Lung$409,375
R01 · FY2022 · HL · contact PI
Conjugate vaccines for prevention and treatment of cryptococcosis$742,433
R01 · FY2021 · AI · contact PI
Exploiting antibody catalysis for treating Cryptococcosis$734,148
R01 · FY2021 · AI · contact PI
The Molecular and Cellular Basis of Infectious Diseases (MCBID) Program$606,813
T32 · FY2021 · AI · contact PI
Synergy of Host Defense Mechanisms in the Lung$409,375
R01 · FY2021 · HL · contact PI
Conjugate vaccines for prevention and treatment of cryptococcosis - COVID-19 Revision Supplement$268,837
R01 · FY2021 · AI · contact PI
Conjugate vaccines for prevention and treatment of cryptococcosis - COVID-19 Revision Supplement$1,313,891
R01 · FY2020 · AI · contact PI
Conjugate vaccines for prevention and treatment of cryptococcosis$742,433
R01 · FY2020 · AI · contact PI
The Molecular and Cellular Basis of Infectious Diseases (MCBID) Program$483,957
T32 · FY2020 · AI · contact PI
Synergy of Host Defense Mechanisms in the Lung$409,375
R01 · FY2020 · HL · contact PI
Biology of Fungal Melanin$533,349
R01 · FY2019 · AI · contact PI
The Molecular and Cellular Basis of Infectious Diseases (MCBID) Program$462,241
T32 · FY2019 · AI · contact PI
Biology of Fungal Melanin$533,349
R01 · FY2018 · AI · contact PI
The Molecular and Cellular Basis of Infectious Diseases (MCBID) Program$466,718
T32 · FY2018 · AI · contact PI
Synergy of Host Defense Mechanisms in the Lung$405,000
R01 · FY2018 · HL · contact PI
Biology of Fungal Melanin$533,349
R01 · FY2017 · AI · contact PI
The Molecular and Cellular Basis of Infectious Diseases (MCBID) Program$458,638
T32 · FY2017 · AI · contact PI
Synergy of Host Defense Mechanisms in the Lung$405,000
R01 · FY2017 · HL · contact PI
The Molecular and Cellular Basis of Infectious Diseases (MCBID) Program$6,687
T32 · FY2017 · AI · contact PI
Biology of Fungal Melanin$533,181
R01 · FY2016 · AI · contact PI
The Molecular and Cellular Basis of Infectious Diseases (MCBID) Program$413,019
T32 · FY2016 · AI · contact PI
Synergy of Host Defense Mechanisms in the Lung$405,000
R01 · FY2016 · HL · contact PI
Molecular Characterization of C. neoformans Antibodies$364,500
R37 · FY2016 · AI · contact PI
Biology of Fungal Melanin$563,341
R01 · FY2015 · AI · contact PI
Synergy of Host Defense Mechanisms in the Lung$405,000
R01 · FY2015 · HL · contact PI
Molecular Characterization of C. neoformans Antibodies$277,267
R37 · FY2015 · AI · contact PI
Molecular Characterization of C. neoformans Antibodies$161,031
R37 · FY2015 · AI · contact PI
Biological and Clinical Impact of Cryptococcal Extralcellular Vesicles$15,656
R37 · FY2015 · AI · contact PI
Atoms-to-Animals: Structural Genomics of Immunity$613,573
U01 · FY2014 · GM · contact PI
Atoms-to-Animals: Structural Genomics of Immunity$480,664
U01 · FY2014 · GM · contact PI
Protective antibodies for Cryptococcal Infections$410,850
R01 · FY2014 · AI · contact PI
Molecular Characterization of C. neoformans Antibodies$375,750
R37 · FY2014 · AI · contact PI
Atoms-to-Animals: Structural Genomics of Immunity$1,055,939
U01 · FY2013 · GM · contact PI
Development of new passive immunization strategies for anthrax$906,932
U54 · FY2013 · AI · contact PI
Biology of Fungal Melanin$444,642
R01 · FY2013 · AI · contact PI
Protective antibodies for Cryptococcal Infections$386,199
R01 · FY2013 · AI · contact PI
Molecular Characterization of C. neoformans Antibodies$353,205
R37 · FY2013 · AI · contact PI
Atoms-to-Animals: Structural Genomics of Immunity$1,094,237
U01 · FY2012 · GM · contact PI
Development of new passive immunization strategies for anthrax$983,096
U54 · FY2012 · AI · contact PI
Biology of Fungal Melanin$466,153
R01 · FY2012 · AI · contact PI
Protective antibodies for Cryptococcal Infections$410,850
R01 · FY2012 · AI · contact PI
Molecular Characterization of C. neoformans Antibodies$374,813
R37 · FY2012 · AI · contact PI
Synergy of Host Defense Mechanisms in the Lung$373,500
R01 · FY2012 · HL · contact PI
Molecular Pathogenesis of Infectious Diseases$319,402
T32 · FY2012 · AI · contact PI
Development of new passive immunization strategies for anthrax$567,768
U54 · FY2011 · AI · contact PI
Biology of Fungal Melanin$466,469
R01 · FY2011 · AI · contact PI
Protective antibodies for Cryptococcal Infections$410,850
R01 · FY2011 · AI · contact PI
Synergy of Host Defense Mechanisms in the Lung$373,500
R01 · FY2011 · HL · contact PI
Molecular Pathogenesis of Infectious Diseases$307,752
T32 · FY2011 · AI · contact PI
Molecular Characterization of C. neoformans Antibodies$279,308
R37 · FY2011 · AI · contact PI
Development of new passive immunization strategies for anthrax$619,753
U54 · FY2010 · AI · contact PI
Biology of Fungal Melanin$471,168
R01 · FY2010 · AI · contact PI
Molecular Characterization of C. neoformans Antibodies$441,075
R37 · FY2010 · AI · contact PI
Protective antibodies for Cryptococcal Infections$415,000
R01 · FY2010 · AI · contact PI
Synergy of Host Defense Mechanisms in the Lung$373,500
R01 · FY2010 · HL · contact PI
Molecular Characterization of C. neoformans Antibodies$282,130
R37 · FY2010 · AI · contact PI
Molecular Pathogenesis of Infectious Diseases$198,333
T32 · FY2010 · AI · contact PI
Development of new passive immunization strategies for anthrax$529,506
U54 · FY2009 · AI · contact PI
Biology of Fungal Melanin$478,446
R01 · FY2009 · AI · contact PI
Synergy of Host Defense Mechanisms in the Lung$373,500
R01 · FY2009 · HL · contact PI
Molecular Characterization of C. neoformans Antibodies$353,125
R37 · FY2009 · AI · contact PI
Molecular Pathogenesis of Infectious Diseases$308,762
T32 · FY2009 · AI · contact PI
B Cell Related Prophylaxis and Therapeutics$835,818
U54 · FY2008 · AI · contact PI
Protective Antibodies for Cryptococcal Infections$397,235
R01 · FY2008 · AI · contact PI
Synergy of Host Defense Mechanisms in the Lung$373,500
R01 · FY2008 · HL · contact PI
Molecular Pathogenesis of Infectious Diseases$306,701
T32 · FY2008 · AI · contact PI
Molecular Characterization of C. neoformans Antibodies$284,981
R37 · FY2008 · AI · contact PI
Molecular Characterization of C. neoformans Antibodies$64,259
R37 · FY2008 · AI · contact PI
Protective Antibodies for Cryptococcal Infections$451,821
R01 · FY2007 · AI · contact PI
Biology of Fungal Melanin$330,395
R01 · FY2007 · AI · contact PI
Molecular Characterization of C. neoformans Antibodies$290,500
R37 · FY2007 · AI · contact PI
Protective Antibodies for Cryptococcal Infections$465,229
R01 · FY2006 · AI · contact PI
Biology of Fungal Melanin$343,475
R01 · FY2006 · AI · contact PI
Molecular Pathogenesis of Infectious Diseases$341,236
T32 · FY2006 · AI · contact PI
Synergy of Host Defense Mechanisms in Lung$326,151
R01 · FY2006 · HL · contact PI
Molecular Characterization of C Neoformans Antibodies$244,613
R01 · FY2006 · AI · contact PI
Protective Antibodies for Cryptococcal Infections$417,500
R01 · FY2005 · AI
Synergy of Host Defense Mechanisms in Lung$384,100
R01 · FY2005 · HL
Biology of Fungal Melanin$354,872
R01 · FY2005 · AI
Molecular Pathogenesis of Infectious Diseases$343,258
T32 · FY2005 · AI
Molecular Characterization of C Neoformans Antibodies$250,500
R01 · FY2005 · AI
Mining slime mold for susceptibility genes to fungi$125,250
R21 · FY2005 · GM
Protective Antibodies for Cryptococcal Infections$51,269
R01 · FY2005 · AI
Protective Antibodies for Cryptococcal Infections$417,500
R01 · FY2004 · AI
Synergy of Host Defense Mechanisms in Lung$384,100
R01 · FY2004 · HL
Biology of Fungal Melanin$357,855
R01 · FY2004 · AI
Molecular Characterization of C Neoformans Antibodies$250,500
R01 · FY2004 · AI
Mining slime mold for susceptibility genes to fungi$125,250
R21 · FY2004 · GM
Synergy of Host Defense Mechanisms in Lung$334,000
R01 · FY2003 · HL
PROTECTIVE ANTIBODIES FOR CRYPTOCOCCAL INFECTIONS$321,481
R01 · FY2003 · AI
Molecular Characterization of C Neoformans Antibodies$293,800
R01 · FY2003 · AI
Biology of Fungal Melanin$188,722
R01 · FY2003 · AI
Synergy of Host Defense Mechanisms in Lung$50,100
R01 · FY2003 · HL
PROTECTIVE ANTIBODIES FOR CRYPTOCOCCAL INFECTIONS$347,159
R01 · FY2002 · AI
Synergy of Host Defense Mechanisms in Lung$334,000
R01 · FY2002 · HL
Molecular Characterization of C Neoformans Antibodies$250,750
R01 · FY2002 · AI
PROTECTIVE ANTIBODIES FOR CRYPTOCOCCAL INFECTIONS$53,467
R03 · FY2002 · TW
PROTECTIVE ANTIBODIES FOR CRYPTOCOCCAL INFECTIONS$322,001
R01 · FY2001 · AI
SYNERGY OF HOST DEFENSE MECHANISMS IN LUNG$252,000
R01 · FY2001 · HL
MOLECULAR CHARACTERIZATION OF C NEOFORMANS ANTIBODIES$187,290
R01 · FY2001 · AI
PROTECTIVE ANTIBODIES FOR CRYPTOCOCCAL INFECTIONS$53,600
R03 · FY2001 · TW
PROTECTIVE ANTIBODIES FOR CRYPTOCOCCAL INFECTIONS$326,774
R01 · FY2000 · AI
SYNERGY OF HOST DEFENSE MECHANISMS IN LUNG$252,000
R01 · FY2000 · HL
MOLECULAR CHARACTERIZATION OF C NEOFORMANS ANTIBODIES$181,835
R01 · FY2000 · AI
PROTECTIVE ANTIBODIES FOR CRYPTOCOCCAL INFECTIONS$53,626
R03 · FY2000 · TW